“STUDY OF THE HYPOGLYCEMIC AND CARDIOPROTECTIVE EFFECT OF EMPAGLIFLOZIN IN THERAPY OF PATIENTS WITH TYPE 2 DIABETES MELLITUS” (2023) Research Focus International Scientific Journal, 2(1), pp. 11–19. doi:10.66073/researchfocus.v2i1.2819.